Seegene, Inc. (KOSDAQ:096530)
32,400
-450 (-1.37%)
Jun 5, 2025, 3:30 PM KST
Seegene Revenue
Seegene had revenue of 116.00B KRW in the quarter ending March 31, 2025, with 28.96% growth. This brings the company's revenue in the last twelve months to 440.30B, up 19.88% year-over-year. In the year 2024, Seegene had annual revenue of 414.25B with 12.76% growth.
Revenue (ttm)
440.30B
Revenue Growth
+19.88%
P/S Ratio
3.39
Revenue / Employee
6.99B
Employees
63
Market Cap
1,494.82B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 414.25B | 46.88B | 12.76% |
Dec 31, 2023 | 367.38B | -486.19B | -56.96% |
Dec 31, 2022 | 853.56B | -517.27B | -37.73% |
Dec 31, 2021 | 1,370.83B | 245.62B | 21.83% |
Dec 31, 2020 | 1,125.22B | 1,003.26B | 822.66% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |
LigaChem Biosciences | 146.42B |